Effects of DPP-4 Inhibition on Triglycerides

NCT01527747 · clinicaltrials.gov ↗

PHASE4

Phase

SUSPENDED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Funding

Conditions

Type 2 Diabetes
Hypertriglyceridemia

Interventions

DRUG: Saxagliptin

Sponsor

Oregon Health and Science University